Search results
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 3 days agoZacks Rank Teva currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks...
Head-To-Head Survey: Ionis Pharmaceuticals (NASDAQ:IONS) versus Nurix Therapeutics (NASDAQ:NRIX)
ETF DAILY NEWS· 2 days agoNurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both medical companies, but which is the better stock? We ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 7 days agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Climate change to drive multiple sclerosis cases, fuel treatment market: Report
Investing.com· 6 hours agoNew Delhi, June 7 (IANS) Climate change is likely to have a significant impact on the rise in...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga via Yahoo Finance· 7 days agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
Zacks· 1 day agoFree Report) . Will the recent positive trend continue leading up to its next earnings release, or is Denali Therapeutics due for a pullback? Before we dive into how investors and analysts have ...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 3 days agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals - Regeneron Pharmaceuticals...
Benzinga· 3 days agoPharmaceuticals analyst ratings. About Regeneron Pharmaceuticals Regeneron Pharmaceuticals discovers, develops, and commercializes products ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 13 hours agoParacetamol Market size is set to grow by USD 929.4 million from 2024-2028, Significant use of paracetamol as API in large number of OTC drugs to boost the market growth, Technavio PR Newswire NEW YORK, June 6, 2024 NEW YORK, June 6, 2024 /PRNewswire
Why Counterfeit Ozempic Is a Global-Growth Industry
Vanity Fair· 3 days agoMeanwhile, the cost of the GLP-1 drugs—roughly $12,000 a year without insurance—places them beyond the reach of most patients who need them. Apovian’s...